Addiction and mental health treatment, delivered virtually across the U.S. Louisville, CO, May 14, 2026 (GLOBE NEWSWIRE) -- Red Ribbon Recovery Colorado is now providing virtual mental health and ...

Imviva’s ASGCT presentation highlights encouraging clinical responses in SLE. Among 18 evaluable patients with SLE/lupus nephritis (LN) treated with CTA313, with a median follow-up of six months: 50% ...

DentPrime has responded to this growing concern by launching a new International Complication Protection Program designed for patients seeking dental treatment in Turkey.

The recognition highlights the transformative potential of Rarecells’ ISET® technology, which enables low-cost, ultra-sensitive and highly specific detection of weak cancer signals in blood, ...

Presented improved editing data in non-human primates (NHP) for sickle cell disease (SCD), demonstrating a single dose of Gene Writer achieved an average of 85% of long-term hematopoietic stem cells ...

Lanier Recovery Center opens in Suwanee to give Atlanta-area individuals and families a trusted local resource for addiction treatment and mental health care.

As Zhittya Genesis Medicine, Inc., a Nevada-based biopharmaceutical company developing recombinant human Fibroblast Growth Factor-1 (FGF-1) therapies, marks the four-year anniversary of its intranasal ...

Woodstock, GA, May 14, 2026 (GLOBE NEWSWIRE) -- Inner Voyage Recovery Center, a leading drug and alcohol rehab based in Woodstock, Georgia, has launched a virtual intensive outpatient program (IOP), ...

Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today announced the publication of results from the RAGE¹ (Ruptured Aneurysms Treated ...

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a global leader in epigenetics, today reported financial results for the three months ended March ...

Copenhagen, Denmark, May 14, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the future of metabolic health, today ...

The report is based on two surveys conducted in March 2026: a Censuswide survey of 250 U.S. C-level executives at large, multi-site health systems with self-funded plans, and a Pollfish survey of 352 ...